Cargando…
First-in-Class Star-Shaped Triazine Dendrimers Endowed with MMP-9 Inhibition and VEGF Suppression Capacity: Design, Synthesis, and Anticancer Evaluation
[Image: see text] Off-target side effects are major challenges hindering the clinical success of matrix metalloproteinase (MMP) inhibitors. Various targeting strategies revitalized MMP research to eliminate this drawback. Herein, we developed s-triazine-based dendrimeric architecture not only amenab...
Autores principales: | Haiba, Nesreen S., Khalil, Hosam H., Bergas, Ahmed, Abu-Serie, Marwa M., Khattab, Sherine N., Teleb, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219090/ https://www.ncbi.nlm.nih.gov/pubmed/35755386 http://dx.doi.org/10.1021/acsomega.2c01949 |
Ejemplares similares
-
Synthesis, characterization and evaluation of 1,3,5-triazine aminobenzoic acid derivatives for their antimicrobial activity
por: Al-Zaydi, Khadijah M., et al.
Publicado: (2017) -
Two Decades of Triazine Dendrimers
por: Simanek, Eric E.
Publicado: (2021) -
Synthesis and Preliminary Biological Evaluation of 1,3,5-Triazine Amino Acid Derivatives to Study Their MAO Inhibitors
por: Khattab, Sherine N., et al.
Publicado: (2015) -
Unconventional Approaches to Prepare Triazine-Based Liquid Crystal Dendrimers
por: Lu, Yao-Chih, et al.
Publicado: (2021) -
Thermoregulated Coacervation, Metal-Encapsulation and Nanoparticle Synthesis in Novel Triazine Dendrimers
por: Ramírez-Crescencio, Fermín, et al.
Publicado: (2016)